Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-02
2011-08-02
Pryor, Alton (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07989474
ABSTRACT:
The invention relates to a method of treating immunologic diseases or pathological conditions involving an immunologic component using certain Lck inhibitors already known as kinase inhibitors for therapy in oncology, optionally in combination with one or more other drugs selected from NSAIDs, steroids, DMARDs, immunsuppressives, biologic response modifiers and antinfectives, pharmaceutical compositions comprising said Lck inhibitors together with said other drugs, and the use of the Lck inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component.
REFERENCES:
patent: 5922741 (1999-07-01), Davis et al.
patent: 6093716 (2000-07-01), Davis et al.
patent: 6169106 (2001-01-01), Heckel et al.
patent: 6245760 (2001-06-01), He et al.
patent: 6762180 (2004-07-01), Roth et al.
patent: 6794395 (2004-09-01), Roth et al.
patent: 7119093 (2006-10-01), Roth et al.
patent: 7148249 (2006-12-01), Kley et al.
patent: 7160901 (2007-01-01), Walter et al.
patent: 2003/0069299 (2003-04-01), Walter et al.
patent: 2003/0166929 (2003-09-01), Snow et al.
patent: 0018734 (2000-04-01), None
patent: 0073297 (2000-12-01), None
patent: 0127080 (2001-04-01), None
patent: 0127081 (2001-04-01), None
patent: WO - 0127081 (2001-04-01), None
patent: 0140215 (2001-06-01), None
patent: 0172711 (2001-10-01), None
U.S. Appl. No. 11/275,223.
Colbatzky Florian
Ernest Steffan
Hauptmann Rudolf
Heckel Armin
Hilberg Frank
Boehringer Ingelheim Pharma GmbH & Co. KG
Morris Michael P.
Pryor Alton
Stempel Alan R.
LandOfFree
Use of Lck inhibitors for treatment of immunologic diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of Lck inhibitors for treatment of immunologic diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Lck inhibitors for treatment of immunologic diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2624612